Inhibition of 6-Phosphogluconate Dehydrogenase Reverses Epirubicin Resistance Through Metabolic Reprograming in Triple-Negative Breast Cancer Cells

At present, chemotherapy is the most effective strategy for treating triple-negative breast cancer (TNBC), but its efficacy was limited by the development of chemo-resistance. The exact mechanism of chemoresistance still remains unclear. This study aims to examine whether 6-phosphogluconate dehydrog...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jiali, Ren, Guosheng, Cheng, Qiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Role of metabolic processes in cancer progression and metastasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416659/
https://www.ncbi.nlm.nih.gov/pubmed/37559469
http://dx.doi.org/10.1177/15330338231190737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416659/
https://www.ncbi.nlm.nih.gov/pubmed/37559469
http://dx.doi.org/10.1177/15330338231190737

Ejemplares similares